Mohamed Alswah

发表

SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL PYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVES OF EXPECTED ANTICANCER ACTIVITY

Mohamed Alswah, 2021 .

A New Theobromine-Based EGFRWT and EGFRT790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies

Ibrahim M. Ibrahim, I. Eissa, A. Metwaly, 2022, Processes.

Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

I. Eissa, M. S. Taghour, Mohamed S Alesawy, 2020, Archiv der Pharmazie.

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects

Hany E. A. Ahmed, A. Bayoumi, Ahmed Elmorsy, 2017, Molecules.

The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors

Hany E. A. Ahmed, Khaled El-Adl, Hamada S. Abulkhair, 2021, New Journal of Chemistry.

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents

A. El-Morsy, Adel H. Ghiaty, Kamal M El-Gamal, 2013, ISRN organic chemistry.

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

Farag F. Sherbiny, Hany E. A. Ahmed, T. H. Afifi, 2020, Bioorganic chemistry.

Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors

I. Eissa, A. El-Morsy, Kamal M El-Gamal, 2018, Journal of Molecular Structure.

5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations

Khaled El-Adl, Helmy M. Sakr, Mohamed Alswah, 2020, Archiv der Pharmazie.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum towards Carbapenem-Resistant Bacteria.

M. Seleem, H. Gowher, Nader S. Abutaleb, 2019, Journal of medicinal chemistry.

Design, synthesis, anticancer, and docking of some S‐ and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors

Khaled El-Adl, A. Abdel-Rahman, Asmaa M A Omar, 2021, Archiv der Pharmazie.

Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists

M. Abdelgawad, M. Ghoneim, M. M. Khalifa, 2022, Pharmaceuticals.

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects

Hany E. A. Ahmed, A. Bayoumi, Ahmed Elmorsy, 2017, Molecules.

Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies

Hany E. A. Ahmed, Mohammed Almaghrabi, Mohamed M. Elsebaei, 2023, International journal of molecular sciences.

N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity.

Hany E. A. Ahmed, A. Shati, M. Alfaifi, 2024, Bioorganic chemistry.